Kaya, Özge, et al. “Long-Term Omalizumab Therapy in Patients With Chronic Spontaneous Urticaria: Does It Increase the Risk of COVID-19?”. Dermatology Practical & Conceptual, vol. 13, no. 3, July 2023, p. e2023145, https://doi.org/10.5826/dpc.1303a145.